Skip to content
The Dawning of a New Era in the Management of Prurigo Nodularis: A Focus on the Patient Experience, Differential Diagnosis and Emerging Treatment Options Evaluation (ID: i833-3)
*
1.
How many patients with PN do you manage per month?
(Required.)
1 to 10
11 to 25
26 to 50
I am not directly involved in patient care
*
2.
After participating in this activity, how confident are you in the management of patients with PN in your practice?
(Required.)
Very confident
Confident
Neutral
Little confidence
No confidence
*
3.
How committed are you to making changes in your practice based on your participation in this activity?
(Required.)
Very committed
Committed
Neutral
Not committed
I do not plan to make changes
If not committed or do not plan to make changes, please indicate reason
*
4.
Which of the following best describes the impact of this activity on your performance?
(Required.)
I gained new strategies/skills/information I can apply to my area of practice
I need more information before I can change my practice
My practice is already consistent with the information presented
This activity will not change my practice
*
5.
Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.
(Required.)
Asking more detailed and specific questions about the impact of PN on the patient’s quality of life
Selecting a treatment that will target inflammatory drivers of PN
EADV major criteria to evaluate patients who have nodular/papular skin manifestations that appear to resemble PN
Selecting a treatment based on clinical trial findings of reduction in itch and improvement in lesion healing
*
6.
What barriers do you see to making changes in your practice? Please select all that apply.
(Required.)
Lack of knowledge regarding evidence-based strategies
Lack of convincing evidence to warrant change
Lack of time/resources to consider change
Insurance, reimbursement, or legal issues
Conflicting guidelines or evidence
Patient compliance and/or patient resource barriers
Other (please specify)
*
7.
Please rate your level of agreement by checking the appropriate rating.
Sonja Ständer, MD, effectively:
(Required.)
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
Presented the Material
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
Avoided Commercial Bias
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
*
8.
Please rate your level of agreement by checking the appropriate rating.
Gil Yosipovitch, MD, effectively:
(Required.)
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
Presented the Material
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
Avoided Commercial Bias
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
*
9.
Please rate your level of agreement by checking the appropriate rating.
The educational activity:
(Required.)
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
Met the identified learning objectives
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
Enhanced my current knowledge base
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
Addressed my most pressing questions
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
Promoted improvements or quality in health care
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
Was scientifically rigorous and evidence based
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
Avoided commercial bias or influence
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
10.
As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?
11.
Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities for prurigo nodularis:
12.
If you indicated that you perceived commercial bias or influence, please describe: